{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:42:29Z","timestamp":1787503349481,"version":"build-2736575974"},"reference-count":46,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Natural Science Foundation Project of Chongqing","award":["cstc2017jcyjB0161"],"award-info":[{"award-number":["cstc2017jcyjB0161"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672377"],"award-info":[{"award-number":["81672377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31671464"],"award-info":[{"award-number":["31671464"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.bbrc.2017.06.103","type":"journal-article","created":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T01:01:44Z","timestamp":1497920504000},"page":"693-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein"],"prefix":"10.1016","volume":"490","author":[{"given":"Haojun","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengtian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.06.103_bib1","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrc.2017.06.103_bib2","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21161","article-title":"Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma","volume":"62","author":"Maluccio","year":"2012","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrc.2017.06.103_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2017.06.103_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2017.04.009","article-title":"Non-coding RNA in hepatocellular carcinoma: mechanisms, biomarkers and therapeutic targets","author":"Klingenberg","year":"2017","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.bbrc.2017.06.103_bib5","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.4254\/wjh.v7.i28.2781","article-title":"Long noncoding RNAs in hepatocellular carcinoma: novel insights into their mechanism","volume":"7","author":"Liu","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.bbrc.2017.06.103_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1053\/j.gastro.2006.08.026","article-title":"Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA","volume":"132","author":"Panzitt","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbrc.2017.06.103_bib7","doi-asserted-by":"crossref","DOI":"10.1089\/dna.2017.3686","article-title":"Long noncoding RNA highly upregulated in liver cancer activates p53-p21 pathway and promotes nasopharyngeal carcinoma cell growth","author":"Jiang","year":"2017","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbrc.2017.06.103_bib8","doi-asserted-by":"crossref","first-page":"51763","DOI":"10.18632\/oncotarget.10107","article-title":"Long non-coding RNA HULC as a novel serum biomarker for diagnosis and prognosis prediction of gastric cancer","volume":"7","author":"Jin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2017.06.103_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.gene.2016.08.002","article-title":"Long noncoding RNA HULC promotes colorectal carcinoma progression through epigenetically repressing NKD2 expression","volume":"592","author":"Yang","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.bbrc.2017.06.103_bib10","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1159\/000468005","article-title":"The value of lncRNA HULC as a prognostic factor for survival of cancer outcome: a meta-analysis","volume":"41","author":"Chen","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.bbrc.2017.06.103_bib11","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1093\/nar\/gkq285","article-title":"CREB up-regulates long non-coding RNA, HULC expression through interaction with microRNA-372 in liver cancer","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbrc.2017.06.103_bib12","doi-asserted-by":"crossref","first-page":"26302","DOI":"10.1074\/jbc.M112.342113","article-title":"Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18","volume":"287","author":"Du","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2017.06.103_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13555-016-0166-x","article-title":"Cyclooxygenase in cancer prevention and treatments for actinic keratosis","volume":"7","author":"Thomas","year":"2017","journal-title":"Dermatol Ther. (Heidelb)"},{"key":"10.1016\/j.bbrc.2017.06.103_bib14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2004.047100","article-title":"Prostaglandins and cancer","volume":"55","author":"Wang","year":"2006","journal-title":"Gut"},{"key":"10.1016\/j.bbrc.2017.06.103_bib15","doi-asserted-by":"crossref","first-page":"15732","DOI":"10.18632\/oncotarget.14997","article-title":"SerpinB3 upregulates the Cyclooxygenase-2\/beta-Catenin positive loop in colorectal cancer","volume":"8","author":"Terrin","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2017.06.103_bib16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.eururo.2008.04.043","article-title":"Overexpression of ELAV-like protein HuR is associated with increased COX-2 expression in atrophy, high-grade prostatic intraepithelial neoplasia, and incidental prostate cancer in cystoprostatectomies","volume":"56","author":"Barbisan","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bbrc.2017.06.103_bib17","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1158\/2159-8290.CD-11-0241","article-title":"Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women","volume":"2","author":"Subbaramaiah","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbrc.2017.06.103_bib18","doi-asserted-by":"crossref","first-page":"132320","DOI":"10.1155\/2014\/132320","article-title":"COX-2 inhibitors and gastric cancer","volume":"2014","author":"Wang","year":"2014","journal-title":"Gastroenterol. Res. Pract."},{"key":"10.1016\/j.bbrc.2017.06.103_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2015.11.007","article-title":"Cyclooxygenase-2 inhibitors in lung cancer treatment: bench to bed","volume":"769","author":"Liu","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2017.06.103_bib20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ctrv.2005.10.004","article-title":"Cyclooxygenase-2 in hepatocellular carcinoma","volume":"32","author":"Wu","year":"2006","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.bbrc.2017.06.103_bib21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.5114\/aoms.2016.61916","article-title":"Prognostic significance of cyclooxygenase-2 expression in patients with hepatocellular carcinoma: a meta-analysis","volume":"12","author":"Chen","year":"2016","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bbrc.2017.06.103_bib22","article-title":"Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice","author":"Chen","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2017.06.103_bib23","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.bcp.2004.05.031","article-title":"Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention","volume":"68","author":"Chun","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbrc.2017.06.103_bib24","doi-asserted-by":"crossref","first-page":"15173","DOI":"10.18632\/oncotarget.7908","article-title":"MiR-26a and miR-144 inhibit proliferation and metastasis of esophageal squamous cell cancer by inhibiting cyclooxygenase-2","volume":"7","author":"Shao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2017.06.103_bib25","doi-asserted-by":"crossref","first-page":"e01776","DOI":"10.7554\/eLife.01776","article-title":"p50-associated COX-2 extragenic RNA (PACER) activates COX-2 gene expression by occluding repressive NF-kappaB complexes","volume":"3","author":"Krawczyk","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.bbrc.2017.06.103_bib26","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3892\/mmr.2017.6161","article-title":"Expression of cyclooxygenase-2 is correlated with lncRNA-COX-2 in cirrhotic mice induced by carbon tetrachloride","volume":"15","author":"Tang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbrc.2017.06.103_bib27","doi-asserted-by":"crossref","first-page":"e1074376","DOI":"10.1080\/2162402X.2015.1074376","article-title":"TLR4 signaling promotes a COX-2\/PGE2\/STAT3 positive feedback loop in hepatocellular carcinoma (HCC) cells","volume":"5","author":"Lin","year":"2016","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbrc.2017.06.103_bib28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/MEG.0b013e328306a3a2","article-title":"Highly upregulated in liver cancer noncoding RNA is overexpressed in hepatic colorectal metastasis","volume":"21","author":"Matouk","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbrc.2017.06.103_bib29","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.bbrc.2015.03.093","article-title":"USP22 acts as an oncogene by regulating the stability of cyclooxygenase-2 in non-small cell lung cancer","volume":"460","author":"Xiao","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.06.103_bib30","first-page":"12956","article-title":"Molecular mechanism of HEIH and HULC in the proliferation and invasion of hepatoma cells","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bbrc.2017.06.103_bib31","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/hep.29010","article-title":"Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis","volume":"65","author":"Li","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbrc.2017.06.103_bib32","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cell.2014.03.008","article-title":"The noncoding RNA revolution-trashing old rules to forge new ones","volume":"157","author":"Cech","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2017.06.103_bib33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrd.2016.117","article-title":"Non-coding RNAs as drug targets","volume":"16","author":"Matsui","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2017.06.103_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.tips.2013.05.003","article-title":"Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection","volume":"34","author":"Jiang","year":"2013","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.bbrc.2017.06.103_bib35","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000452315","article-title":"The role of NSAIDs in breast cancer prevention and relapse: current evidence and future perspectives","volume":"11","author":"Moris","year":"2016","journal-title":"Breast Care (Basel)"},{"key":"10.1016\/j.bbrc.2017.06.103_bib36","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.12706","article-title":"MiR-26b suppresses cell proliferation and invasion by targeting cyclooxygenase 2 in human glioblastoma","author":"Jiang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2017.06.103_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40659-016-0071-x","article-title":"Wnt-5a-regulated miR-101b controls COX2 expression in hippocampal neurons","volume":"49","author":"Codocedo","year":"2016","journal-title":"Biol. Res."},{"key":"10.1016\/j.bbrc.2017.06.103_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.molcel.2007.12.015","article-title":"The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression","volume":"29","author":"Zhang","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2017.06.103_bib39","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.molcel.2012.03.024","article-title":"USP22 antagonizes p53 transcriptional activation by deubiquitinating Sirt1 to suppress cell apoptosis and is required for mouse embryonic development","volume":"46","author":"Lin","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2017.06.103_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2016.521","article-title":"LncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells","author":"Xiong","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2017.06.103_bib41","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.humpath.2015.04.001","article-title":"Decreased H2B monoubiquitination and overexpression of ubiquitin-specific protease enzyme 22 in malignant colon carcinoma","volume":"46","author":"Wang","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bbrc.2017.06.103_bib42","doi-asserted-by":"crossref","first-page":"12654","DOI":"10.18632\/oncotarget.3705","article-title":"High USP22 expression indicates poor prognosis in hepatocellular carcinoma","volume":"6","author":"Tang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2017.06.103_bib43","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3727\/096504016X14772395226335","article-title":"Downregulation of ubiquitin-specific protease 22 inhibits proliferation, invasion and EMT in osteosarcoma cells","volume":"25","author":"Zhang","year":"2017","journal-title":"Oncol. Res."},{"key":"10.1016\/j.bbrc.2017.06.103_bib44","doi-asserted-by":"crossref","first-page":"32683","DOI":"10.18632\/oncotarget.15950","article-title":"USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2017.06.103_bib45","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00432-011-0998-9","article-title":"Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer","volume":"137","author":"Zhang","year":"2011","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bbrc.2017.06.103_bib46","doi-asserted-by":"crossref","first-page":"24728","DOI":"10.18632\/oncotarget.15798","article-title":"USP22 knockdown enhanced chemosensitivity of hepatocellular carcinoma cells to 5-Fu by up-regulation of Smad4 and suppression of Akt","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17312342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17312342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T08:14:30Z","timestamp":1602317670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17312342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0006291X17312342"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.103","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"lncRNA HULC promotes the growth of hepatocellular carcinoma cells via stabilizing COX-2 protein","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}